REV1–DHX36 Coordinates G-Quadruplex Tolerance

G-quadruplexes (G4s) are stable, guanine-rich DNA structures that can obstruct replication forks and create opportunities for mutagenesis, fork slowing, and persistent single-stranded DNA. In Nucleic Acids Research, Ketkar and colleagues define how two genome-maintenance proteins, the Y-family polymerase REV1 and the G4 helicase DHX36, cooperate to help human cells replicate through these difficult templates. The central contribution is a mechanistic connection between G4 unwinding, replication-fork progression, and suppression of single-stranded DNA gaps.

Study Background and Research Question

G4 structures form at guanine-rich sequences and are favored in genomic regions that can regulate transcription, replication, and chromosome architecture. Their biological effects are context dependent: a transient structure may be resolved without lasting damage, whereas prolonged stabilization can impede polymerases, uncouple helicase and polymerase activities, and expose vulnerable single-stranded DNA. The problem is especially important because G4s are not conventional lesions. They are alternative DNA conformations that challenge replication machinery through their stability, structural diversity, and potential for oxidative modification.

Earlier work had implicated REV1 in replication near G4-forming sequences and had linked G4 bypass to helicases such as FANCJ. However, it remained unclear how G4 resolution is coordinated with continued DNA synthesis and how cells limit the formation of post-replicative single-stranded DNA gaps. The reference study asks whether REV1 has a non-catalytic organizing role in this process and whether it communicates directly with a helicase capable of resolving G4 structures. The authors focused on DHX36, a helicase with established G4-recognition and unwinding activities.

In the reference study, the authors therefore examined three connected questions: how REV1 affects fork movement through G4-containing regions, whether REV1 suppresses replication-associated single-stranded DNA gaps, and how REV1 and DHX36 are physically and functionally coupled.

Key Innovation from the Reference Study

The principal innovation is the identification of a direct REV1–DHX36 interaction that supports a two-tiered response to G4-associated replication stress. In this model, DHX36 contributes to the physical resolution of the G4 structure, while REV1 organizes the local replication response and restrains excessive reliance on PrimPol-mediated repriming. REV1 is therefore presented not simply as a mutagenic polymerase or a scaffold for other translesion synthesis factors, but as a coordinator that links helicase activity to the continuity of DNA synthesis.

The interaction depends on the C-terminal domain of REV1 and a newly defined interaction region at the C-terminus of DHX36. This domain-level mapping is important because it separates the structural partnership from the catalytic activity of REV1. It also provides a molecular handle for future studies of how protein–protein interactions regulate G4 tolerance without necessarily changing the intrinsic enzymatic properties of either factor.

A second conceptual advance is the proposed separation between acute and prolonged G4 stress. Under manageable conditions, REV1 and DHX36 can cooperate near the replication machinery. When G4 structures remain stabilized for longer periods, the proteins become uncoupled: DHX36 accumulates at a site distal from REV1 and the DNA synthesis apparatus. The authors interpret this spatial separation as evidence that helicase recruitment alone cannot guarantee productive fork recovery once the damage or structural obstacle exceeds the capacity of the normal replication response.

Methods and Experimental Design Insights

The experimental strategy combined cellular genetics, replication analysis, G4-stabilization challenges, DNA-damage signaling measurements, and biochemical interaction studies. REV1-deficient and control cells were compared during normal growth and after treatment with pyridostatin (PDS), a compound used in the study to stabilize G4 structures. Fork elongation behavior was assessed to determine whether cells continued synthesis through or around G4-associated barriers. The investigators also examined single-stranded DNA gap suppression, nuclear G4 signal, and ATM/ATR pathway activation.

Strand-specific analysis was particularly informative. The study distinguished mutagenic G4 replication on leading- and lagging-strand templates rather than treating G4 bypass as a single uniform event. This design revealed that REV1 loss had a stronger effect on leading-strand mutagenic replication, whereas lagging-strand mutagenesis showed greater sensitivity to PDS. Such strand asymmetry helps distinguish polymerase-dependent bypass from repriming, template switching, or other fork-restart processes.

The biochemical component tested whether the REV1–DHX36 association was direct and then mapped the regions required for binding. Cellular localization experiments extended these findings by asking whether the two proteins remain spatially coupled when G4 structures are stabilized. Together, these approaches move from phenotype to mechanism: replication defects establish functional relevance, domain mapping identifies the physical interface, and localization studies show how that interface changes under persistent stress.

Protocol Parameters

• REV1 comparison: Analyze matched control and REV1-deficient conditions to separate REV1-dependent effects from general consequences of replication stress.
• G4 challenge: Use PDS or another validated G4-stabilizing condition only within a concentration and exposure range established for the selected cell system; the reference study supports the biological rationale but does not define a universal dose for all models.
• Replication readouts: Pair fork-elongation measurements with assays for single-stranded DNA gaps, because normal-looking bulk DNA synthesis may coexist with defective gap suppression.
• Structure and signaling readouts: Measure nuclear G4 accumulation together with ATM/ATR-associated signaling rather than interpreting either marker in isolation.
• Interaction analysis: When testing REV1–DHX36 coupling, include the REV1 C-terminal domain and the DHX36 C-terminal interaction region as separate mapping variables.
• Strand resolution: Where technically feasible, distinguish leading- and lagging-strand bypass to avoid masking strand-specific effects in aggregate mutagenesis data.

These parameters are workflow suggestions derived from the study design, not universal operating conditions. Cell type, G4 sequence context, exposure duration, and the method used to quantify gaps or fork progression can all change the apparent magnitude of the phenotype.

Core Findings and Why They Matter

REV1 loss changed the way replication forks elongated near G4 structures. Instead of maintaining the usual REV1-supported response, deficient cells shifted toward a PrimPol-driven mechanism. This finding suggests that PrimPol can provide an alternative route for continued synthesis, but that the substitute pathway is not functionally equivalent. In particular, REV1-deficient cells showed defective suppression of single-stranded DNA gaps after G4 stabilization.

The distinction matters for genome integrity. A fork that resumes synthesis is not necessarily a fork that has restored chromosome continuity. Persistent gaps can become substrates for recombination, post-replicative repair, or secondary DNA damage. The work therefore broadens the definition of successful G4 tolerance from simple fork movement to coordinated completion and stabilization of newly replicated DNA.

REV1 deficiency also increased nuclear G4 signal and amplified ATM/ATR signaling. These observations place the REV1–DHX36 system upstream of, or functionally connected to, the cellular DNA damage response. They do not show that REV1 directly activates ATM or ATR. Rather, they indicate that impaired G4 handling produces structural or replication intermediates that engage checkpoint signaling. Cells lacking REV1 were correspondingly more sensitive to G4-stabilizing agents, consistent with a reduced capacity to buffer persistent replication obstacles.

The strand-specific results add another layer of interpretation. Leading-strand mutagenic G4 replication was more strongly affected by REV1 loss, while lagging-strand mutagenesis was more responsive to PDS. This indicates that G4 bypass is shaped by the geometry of the replication fork and by the timing of template exposure. It also cautions against using a single mutation or survival endpoint to infer the underlying bypass pathway.

Finally, the direct REV1–DHX36 interaction explains how a scaffold-like function can be integrated with G4 helicase activity. Prolonged G4 stabilization disrupted the normal association and displaced DHX36 from the immediate DNA synthesis environment. The result is a model in which the first tier resolves or manages the structure near the fork, while the second tier limits gap formation and coordinates downstream tolerance. When stabilization persists, these tiers become uncoupled and the replication response loses efficiency.

Comparison with Existing Internal Articles

The internal article REV1-DHX36 Interaction Promotes Replication Across G-Quadruplex DNA presents a closely related interpretation of the same mechanistic axis. Its emphasis on REV1 as a coordinator of DHX36 activity and genome stability is consistent with the reference study. The present paper adds important experimental resolution by distinguishing leading- and lagging-strand outcomes, identifying the DHX36 C-terminal interaction region, and showing that prolonged G4 stabilization can spatially uncouple DHX36 from REV1 and DNA synthesis.

For researchers, the internal article is best used as a conceptual companion rather than as an independent validation source. The primary evidence remains the Nucleic Acids Research study, particularly for claims about PrimPol dependence, gap suppression, G4 accumulation, and ATM/ATR signaling.

Limitations and Transferability

The findings establish a strong mechanistic framework, but several boundaries should be kept in view. First, the work centers on cellular and biochemical models of G4 replication. G4 abundance, sequence distribution, chromatin state, and replication timing vary across cell types, so the strength of REV1 dependence may not be uniform in normal tissues, transformed cells, or different genomic regions.

Second, PDS is a useful experimental probe of G4 stabilization, but pharmacological stabilization does not reproduce every endogenous source of G4-associated stress. A response observed after PDS treatment may reflect both the structure itself and the duration or intensity of its stabilization. Genetic perturbation, locus-specific measurements, and orthogonal G4-manipulation strategies would help test how broadly the model applies.

Third, increased ATM/ATR signaling is an important consequence of REV1 deficiency, but the study does not establish that checkpoint activation is the sole cause of reduced viability or drug sensitivity. Replication gaps, altered polymerase usage, unresolved structures, and repair-pathway engagement may all contribute. Likewise, the paper does not directly test radiation response, glioma, lung cancer, or pharmacological ATM inhibition. Extending the findings into those settings should therefore be treated as a hypothesis-driven application rather than as a result demonstrated by the reference study.

Research Support Resources

Why this cross-domain matters, maturity, and limitations

G4 stabilization, replication gaps, and ATM/ATR signaling provide a logical bridge to cancer research because tumors frequently experience elevated replication stress. Nevertheless, the bridge is still mechanistic and exploratory: the reference study supports investigation of DNA damage response signaling, but it does not establish clinical efficacy or a universal radiosensitization strategy. Researchers designing such experiments should preserve the paper’s core logic by measuring G4 burden, fork behavior, gap formation, and checkpoint signaling together.

For exploratory workflows involving ATM pathway modulation, researchers can use AZD1390 (SKU B8328), a selective ATM kinase inhibitor, to complement replication-stress assays. The product information describes its use in DNA double-strand break repair inhibitor and radiosensitizer studies, including models relevant to glioblastoma radiosensitization and lung cancer; these applications should be interpreted as separate translational experiments rather than direct validation of the REV1–DHX36 mechanism.